Synergy Pharmaceuticals buy tamam
Start price
18.03.17
/
50%
€4.56
Target price
22.05.17
€11.28
Performance (%)
-21.74%
End price
22.05.17
€3.57
Summary
This prediction ended on 22.05.17 with a price of €3.57. The price of Synergy Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.74%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Synergy Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% | 64.626% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% | 109.421% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% | 57.591% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% | 68.003% |
Comments by tamam for this prediction
In the thread Synergy Pharmaceuticals diskutieren
tamam stimmt der Analystenmeinung von 'Buy' zu
Potential Catalysts: SNDA submission for Trulance for IBS-C.
Initial sales of Trulance.
Buyout Offer.
(Vom Mitglied beendet)
Stopped prediction by tamam for Synergy Pharmaceuticals
Synergy Pharmaceuticals
Start price
Target price
Perf. (%)
€2.34
25.09.17
25.09.17
€6.31
13.12.18
13.12.18
-94.98%
13.12.18
13.12.18
Synergy Pharmaceuticals
Start price
Target price
Perf. (%)
€5.93
06.10.15
06.10.15
€10.82
06.04.16
06.04.16
-57.53%
06.04.16
06.04.16